Drug Profile
GW 842166
Alternative Names: 842166; 842166X; GW 842166X; Non-cannabinoid CB2 receptor agonist - GSKLatest Information Update: 02 Aug 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Anti-inflammatories; Non-opioid analgesics; Pyrans; Pyrimidines; Small molecules
- Mechanism of Action Cannabinoid receptor CB2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Dental pain; Musculoskeletal pain